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Abstract
Background: Peripheral tissue inflammation initiates hyperalgesia accompanied by tissue acidosis, nociceptor
activation, and inflammation mediators. Recent studies have suggested a significantly increased expression of acid-
sensing ion channel 3 (ASIC3) in both carrageenan- and complete Freund’s adjuvant (CFA)-induced inflammation.
This study tested the hypothesis that acupuncture is curative for mechanical hyperalgesia induced by peripheral
inflammation.
Methods: Here we used mechanical stimuli to assess behavioral responses in paw and muscle inflammation
induced by carrageenan or CFA. We also used immunohistochemistry staining and western blot methodology to
evaluate the expression of ASIC3 in dorsal root ganglion (DRG) neurons.
Results: In comparison with the control, the inflammation group showed significant mechanical hyperalgesia with
both intraplantar carrageenan and CFA-induced inflammation. Interestingly, both carrageenan- and CFA-induced
hyperalgesia were accompanied by ASIC3 up-regulation in DRG neurons. Furthermore, electroacupuncture (EA) at
the ST36 rescued mechanical hyperalgesia through down-regulation of ASIC3 overexpression in both carrageenan-
and CFA-induced inflammation.
Conclusions: In addition, electrical stimulation at the ST36 acupoint can relieve mechanical hyperalgesia by
attenuating ASIC3 overexpression.
1. Background
Inflammatory pain is crucial, disabling, and difficult to
treat clinically. It includes both cell and non-cell immune
inflammatory components. This type of pain is usually
associated with peripheral tissue damage, ischemia,
hypoxia, acidosis, and inflammation [1,2]. Tissue injury
always results in inflammation that is often accompanied
by sensitization of nerve terminal nociceptors innervating
into the injury site. It is often initiated by a complex sig-
naling to activate a complex response which alters the
excitability of sensory neurons [3,4]. Chronic inflamma-
tion of injured regions usually increases the expression of
inflammatory mediators such as cytokine, interleukin,
proton, histamine, bradykinin, prostaglandin, and mast
cells to activate immune cells and nerve terminals [5].
These mediators can bind to their specific receptors and
further activate nociceptors to enhance the neuronal
transduction to deliver pain signals.
Inflammation pain can be separated into primary
hyperalgesia and secondary hyperalgesia. Recently, an
animal model of inflammation pain was induced by injec-
tion of carrageenan or CFA into the peripheral tissue to
induce both primary and secondary hyperalgesia [6,7]. By
definition, an enhanced nociceptive response to noxious
stimuli in an injury site is defined as primary hyperalge-
sia. For instance, mechanical hyperalgesia of the knee
was initiated with carrageenan injected into the knee
joint [8]. In contrast, an increased nociceptive response
to noxious stimuli outside of the injured area is always
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considered as secondary hyperalgesia. For example,
mechanical and heat hyperalgesia of the paw was
observed in mice after carrageenan inflammation in the
muscle [9]. Inflammation can sensitize nerve nociceptors
both in peripheral and central nerve systems. This can
enhance neuronal excitability and increase responses to
mechanical stimuli following inflammation [10,11]. Dor-
sal root ganglion (DRG), the spinal cord dorsal horn
(SCDH), and brain neurons show increased nociceptive
receptors and a decreased threshold to noxious stimula-
tion during inflammation [12].
Many ion channels and receptors participate in inflam-
mation pain, including acid sensation ion channels 3
(ASIC3), transient receptor potential vanilloid 1
(TRPV1), voltage dependent sodium channel (Nav), and
calcium channels [13]. Several inflammatory reagents
such as carrageenan, kaolin, and Complete Freund’s adju-
vant (CFA) have been widely used in pain investigation.
Carrageenan is often used to produce non-immune-
mediated inflammation [14]. Injection of carrageenan
into the paw or gastrocnemius muscle (GM) can induce
inflammatory responses with an increase of mast cells,
neutrophils, and macrophages. CFA is constituted of an
antigen solution with heat inactivated Mycobacterium
tuberculosis to potentiate the cell-mediated immune
response and inflammation [15]. Microinjection of CFA
into the plantar paw or GM can evoke persistent inflam-
matory hyperalgesia [7,16].
ASIC3 is mainly expressed in peripheral sensory neu-
rons and is the most sensitive channel for acid detection
[17]. ASIC3 can be activated within a narrow range of
acidic pH (7.2-6.9) and enhanced by arachidonic acid and
lactate [18,19]. ASIC3 participated in mechanical but not
heat hyperalgesia after carrageenan-induced inflammation
of the paw and repeated acid injection induced chronic
pain [7,20]. Four genes encode 7 subtypes of receptors:
ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3, ASIC4, and
ASIC5. All of the ASIC superfamily are expressed in sen-
sory neurons, especially ASIC3 [21,22].
Electroacupuncture (EA) belongs to traditional Chinese
medicine (TCM). It has often been used to treat demen-
tia induced by stroke [23], polycystic ovary syndrome
[24], and pain [25]. Acupuncture analgesia is widely
accepted. Recent studies show that the analgesic effect of
acupuncture is mediated by the release of endogenous
opiates [26], serotonin [27], and adenosine [28]. Low fre-
quency electroacupuncture can induce enkephalin and
adenosine release to activate opioid μ receptors and ade-
nosine A1 receptors, respectively. In contrast, high fre-
quency stimulation can release dynorphins to activate 
receptors [26].
Although the analgesic role of acupuncture is well
documented, the detailed mechanisms are still unclear,
especially its relationship to ASIC3. The purpose of this
study was to identify the role of ASIC3 in acupuncture-
mediated analgesia in carrageenan- and CFA-induced
inflammation pain. Primary hyperalgesia was induced
and investigated with an inflammatory inducer delivered
through an intraplantar microinjection. Our results
showed that ASIC3 was necessary for both carrageenan-
and CFA-induced primary mechanical hyperalgesia. We
also found that EA at the Zusanli (ST36) with 2 Hz low
frequency stimulation can reduce the pain threshold by
decreasing the expression of ASIC3 in peripheral DRG
neurons.
2. Methods
2.1 Animals
CD1 mice at 8 to 12 weeks old were used and kept on a
12 h light-dark cycle with sufficient water and food. The
animal behavioral tests were conducted blind with
experimental groups. The usage of these animals was
approved by the Institute of Animal Care and Use Com-
mittee of China Medical University, Taiwan, following
the Guide for the use of Laboratory Animals (National
Academy Press). The number of animals used and their
suffering was minimized.
2.2 EA treatment
EA treatment was applied using stainless steel needles
which were inserted into the muscle layer to a depth of
2-5 mm at ST36. A Trio-300 (Japan) stimulator deliv-
ered electrical square pulses for 20 min with a 100 μs
duration and a 2 Hz frequency. The stimulation ampli-
tude was 1 mA. The same treatment was given to nona-
cupoint (the gluteal muscle) to set as the sham control
group.
2.3 Animal behavior of mechanical hyperalgesia
Mechanical hyperalgesia behavior was tested at 1, 2, 4, and
7 days after intraplantar injections of carrageenan or CFA.
All experiments were performed at room temperature
(approximately 25°C) and the stimuli were applied only
when the animals were calm but not sleeping or grooming.
Mechanical scores were measured by testing the number
of responses to stimulation. Five applications of von Frey
filaments were delivered. Animals were placed on a plexi
wire platform in an acrylic chamber and allowed 1 hr for
acclimatization. A von Frey filament of 0.02 g bending
force was used as the baseline stimulation. A von Frey fila-
ment was applied to each hind paw 5 times, with a 30-sec
interval between each application.
2.4 Immunohistochemistry
Animals were anesthetized with an overdose of chloral
hydrate (400 mg/kg, i.p.) and intracardially perfused with
saline followed by 4% paraformaldehyde. L3-L5 DRG
neurons were immediately dissected and post-fixed with
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4% paraformaldehyde. Post-fixed tissues were then placed
in 30% sucrose for cryoprotection overnight, embedded
in OCT, rapidly frozen using liquid nitrogen, and stored
at -80°C. Frozen sections were cut 15-μm thick on a
cryostat and mounted on glass slides. Slides were incu-
bated with blocking solution containing 3% BSA, 0.1%
Triton X-100, and 0.02% sodium azide in PBS for 2 hours
at room temperature. After blocking, slides were incu-
bated overnight with primary antibodies prepared in a
blocking solution at 4°C (rabbit anti-ASIC3, 1:1000, Alo-
mone Lab, Jerusalem, Israel). The secondary antibodies
were 6 μM Alexa Flour® donkey-anti-rabbit 594 IgG
(Molecular Probes, Carlsbad, CA, USA). The stained
DRG neurons were then examined using an epi-fluores-
cent microscope (Olympus, BX-51, Japan).
2.5 Western blot analysis
DRG neurons were immediately excised to extract pro-
teins. The total protein was prepared by homogenizing the
DRGs in cold radioimmunoprecipitation (RIPA) buffer
containing 50 mM Tris-HCl pH 7.4, 250 mM NaCl, 1%
NP-40, 5 mM EDTA, 50 mM NaF, 1 mM Na3VO4, 0.02%
NaN3 and 1 × protease inhibitor cocktail (AMRESCO).
The extracted proteins (30 μg per sample assessed by BCA
protein assay) were subjected to 8% SDS-Tris glycine gel
electrophoresis and transferred to a PVDF membrane.
The membrane was blocked with 5% nonfat milk in TBST
buffer (10 mM Tris pH 7.5, 100 mM NaCl, 0.1% Tween
20), and incubated with anti-ASIC 3 (1:1000) subtype anti-
body (Alomone Labs Ltd) in TBST with 1% bovine serum
albumin for 1 hour at room temperature. Peroxidase-
conjugated anti-rabbit antibody (1:5000) was used as a sec-
ondary antibody. The bands were visualized by an
enhanced chemiluminescencent substrate kit (PIERCE)
with LAS-3000 Fujifilm (Fuji Photo Film Co. Ltd). Where
applicable, the image intensities of specific bands were
quantified with NIH ImageJ software (Bethesda, MD,
USA).
2.6 RNA isolation and Real-time PCR
DRGs were dissected 24 hours after treatment and frozen
on dry ice. The tissues were stored at -80°C until RNA
extraction. RNA was extracted by Multisource Total
RNA Miniprep Kit (Axygen Biosciences, Union City, CA,
USA) under standard protocol. 600 μg RNA was sub-
jected to reverse-transcription PCR for converting to
cDNA. RNA was first mixed with 1 μl 250 ng Oligo dT18
and 1 μl 10 mM dNTP and heated at 65°C water bath for
5 min and then put on ice for 1 min. 4 μl 5 × First-Stand
Buffer, 1 μl 0.1 M DTT, 1 μl RNaseOut and 1 μl Super-
Script III Reverse Transcriptase (Invitrogen, Carlsbad,
CA, USA) were then added to the mixture. The mixture
was incubated at 50°C for 1 hour and inactivated at 70°C
for 15 minute to complete the reverse transcription.
Asic3 gene expression was measured using FastStart
Universal SYBG Green Master (Roche, Indianapolis, IN,
USA) on ABI 7500 Fast Real-Time PCR system (Applied
Biosystem, Carlsbad, CA, USA). Reactions were per-
formed in duplicate. Asic3 gene expression was normal-
ized to house keeping gene-glyceraldehyde 3-phosphate
dehydrogenase (Gapdh) in each sample. For Asic3, the
primer sequences were 5’-CCCTGTGGACCTGA-
GAACTT-3’ and 5’-CTGCTCACC ACTCCTAAGGG-3’.
And for Gapdh, the primers sequences were 5’-GGAGC-
CAA ACGGGTCATCATCTC-3’ and 5’-GAGGGGC-
CATCCACAGTCTTCT-3’. Data are shown as relative
expression of control groups.
2.7 Statistic analysis
All statistic data are presented as the mean ± standard
error. Statistical significance between control, inflamma-
tion, EA-sham, and EA group was tested using the
ANOVA test, followed by a post hoc Tukey’s test (p <
0.05 was considered statistically significant).
3. Results
3.1 Carrageenan- and CFA-induced inflammatory
hyperalgesia was attenuated using 2 Hz low frequency
EA at the ST36 acupoint
To test the mechanical hyperalgesia in inflammation pain,
the mechanical stimuli were examined in both ipsilateral
and contralateral paws. Figure 1a shows that control,
sham, and acupuncture treated mice had a normal
response to the von Frey filaments following a saline injec-
tion. The saline injection did not induce mechanical
hyperalgesia at 7 days after injection in this series experi-
ments (Figure 1a, 0.8 ± 0.2 of control, 0.9 ± 0.2 of EA-
sham, 0.8 ± 0.1 of EA, n = 9). After carrageenan injection,
mice developed mechanical hyperalgesia with an increase
in the number of withdrawals to mechanical stimuli which
were applied to the paw ipsilateral to the inflammation
side. No hyperalgesia responses were observed on the con-
tralateral sides of the injections (data not shown). These
phenomena were also reported in previous studies [7,29].
At 5 applications of the filaments, carrageenan-induced
inflammatory paws displayed a hyperactive response on
day 1 and maintained it for 7 days. (Figure 1b, solid circle,
2.9 ± 0.3 of day 1 and 2.7 ± 0.4 of day 7, n = 9). To test if
EA treatment plays a role in the development of inflam-
mation pain, EA was delivered at the ST36 acupoint at 2
Hz for 20 min. When the mice received the EA treatment,
mechanical hyperalgesia attenuated at day 7 after intra-
plantar carrageenan injection (Figure 1b, 1.1 ± 0.4, open
square, n = 8). In the sham group, this did not occur in
EA treatment with electrical stimulation at nonacupoint at
day 7 (Figure 1b, 2.3 ± 0.2, open circle, n = 9). To make a
comparison with carrageenan-induced inflammation pain,
EA treatment was investigated to see if it could reverse
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CFA-induced cell-mediated immune inflammation pain.
At 7 days after the intraplantar CFA injection, animals
showed an increased withdrawal to mechanical stimula-
tion which indicated mechanical hyperalgesia (Figure 1c,
solid circle, 2.7 ± 0.3, n = 9). EA treated mice also dis-
played a decreased withdrawal to mechanical stimuli, sug-
gesting that it had a curative effect on CFA-induced
inflammation pain (Figure 1c, open square, 1.3 ± 0.2, n =
9). Figure 1c shows that these effects were not observed in
animals with sham operation (open circle, 2.3 ± 0.3, n =
9). These results significantly reflected the dramatic cura-
tive effect of EA treatment in both carrageenan- and CFA-
induced primary inflammation pain. Similar results were
also observed in secondary pain induced by intramuscular
injection. Figure 1d shows that intramuscular injection of
saline did not produce hyperalgesia in the control, EA-
sham, and ET-ST36 groups. Intramuscular injection of
carrageenan induced mechanical hyperalgesia in the con-
trol group. This pattern was reversed using EA on
the ST36 group (Figure 1e, open square, 1.2 ± 0.2, n = 9)
but not on the EA-sham group (Figure 1e, open circle,
2.2 ± 0.2, n = 9). This phenomenon can also been seen in
CFA-induced secondary pain. Intramuscular injection of
CFA dramatically induced mechanical hyperalgesia which
was subsequently abolished with EA at the ST36 acupoint
(Figure 1f, open square, 1.2 ± 0.1, n = 9). This did not
occur in the sham group (Figure 1f, open circle, 2.2 ± 0.2,
n = 9).
3.2 The expression of ASIC3 was up-regulated at day 4
after intraplantar carrageenan-mediated inflammation
and further down-regulated using 2 Hz EA stimulation
using immunohistochemistry staining
The ASIC3 immunoreactivity in the DRG from the con-
trol animals was examined to test whether the ASIC3-
positive afferents innervating into peripheral tissue sites
played a critical role in inflammation. The results
showed that ASIC3 was observed in control DRG neu-
rons (Figure 2a). The expression patterns were not sig-
nificantly different between the inflamed site and the
contralateral one (Figure 2b). In the carrageenan-
injected mice, the expression of ASIC3 greatly increased,
Figure 1 Primary and secondary inflammation-induced hyperalgesia through carrageenan and CFA injection in paw. Primary and
secondary inflammation-induced hyperalgesia through carrageenan and CFA injection in paw. (a) von Frey filament test in mice from
intraplantar injection of saline. (b) von Frey filament test in mice from intraplantar injection of carrageenan. (c) von Frey filament test in mice
from intraplantar injection of CFA. (d) von Frey filament test in mice from intramuscular injection of saline. (e) von Frey filament test in mice
from intramuscular injection of carrageenan. (f) von Frey filament test in mice from intramuscular injection of CFA. Con: control mice; EA-sham:
needles inserted at the ST36 acupoint without electrical stimulation, EA-ST36: needles inserted at the ST36 acupoint with electrical stimulation. *p
< 0.05, compared to baseline. #p < 0.05, comparison between Con and EA-ST36 groups. CFA = complete Freund’s adjuvant.
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suggesting that ASIC3 participated in carrageenan-
induced inflammation (Figure 2c). Otherwise, the carra-
geenan-induced increase of ASIC3 expression only influ-
enced the ipsilateral site at day 4 after inflammations
(Figure 2d). With the use of 2 Hz EA treatment at the
ST36 acupoint, the effect of the carrageenan-induced
enhancement of ASIC3 expression reduced (Figure 2e).
This EA phenomenon was observed in the inflamed site
but not the contralateral one (Figure 2f). These results
implied that carrageenan-induced inflammation can
increase the expression of ASIC3 and that the effect can
be further down-regulated by a 2 Hz EA application.
3.3 The expression of ASIC3 was up-regulated at day 4
after intraplantar CFA-mediated inflammation and further
down-regulated by 2 Hz EA stimulation using
immunohistochemistry staining
ASIC3 expression during cell immune mediated inflamma-
tion was examined. CFA was intraplantarly injected into
the mice paws to identify this issue. To serve as a control,
ASIC3 immunoreactivity in DRG was confirmed in saline-
injected sham control animals. The results showed that
ASIC3 was exited in control DRG neurons (Figure 3a). The
expression patterns were not significantly different in the
injected or contralateral site (Figure 3b). In CFA-inflamed
Figure 2 ASIC3 was increased in lumbar DRGs. ASIC3 was increased in lumbar DRGs in intraplantar carrageenan-induced hyperalgesia and
further attenuated by EA at ST36 acupoint in mice. (a) ASIC3 immunoreactive neurons were found in lumbar DRGs in ipsilateral site of saline-
injected group. (b) ASIC3 immunoreactive neurons were found in contralateral site of saline-injected group. (c) ASIC3 immunoreactive neurons
were increased in ipsilateral site of carrageenan-induced inflammation. (d) ASIC3 immunoreactive neurons were not increased in contralateral site
of carrageenan-induced inflammation. (e) Carrageenan-induced increase of ASIC3 was attenuated by EA in ipsilateral site of inflammation. (f)
ASIC3 immunoreactive neurons were not altered by EA in contralateral site of inflammation. Arrows indicated immunoreactive neurons of ASIC3.
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mice, the expression of ASIC3 greatly increased. The result
suggested that ASIC3 was involved in CFA-induced
inflammation (Figure 3c). In contrast, the CFA-mediated
enhancement of ASIC3 expression was only observed in
the ipsilateral site but not the contralateral site (Figure 3d).
With the use of 2 Hz EA treatment, the effect of the CFA-
induced enhancement of ASIC3 expression was reduced
(Figure 3e). This EA phenomenon was observed in the
injected site but not the contralateral one (Figure 3f).
These results suggest that CFA-induced inflammation
can increase the expression of ASIC3 and that the
phenomenon can be further down-regulated by a 2 Hz EA
manipulation.
3.4 The quantity of ASIC3 was enhanced by intraplantar
carrageenan injection and reversely down-regulated by
2 Hz EA stimulation using western blot
To determine if the ASIC3 protein quantity was consis-
tently upregulated with inflammation, western blot was
employed. In the control group, ASIC3 proteins were
normally expressed in both ipsilateral (Figure 4a, left
panel, n = 9) and contralateral DRG neurons (Figure 4b,
Figure 3 ASIC3 was increased in lumbar DRGs in intraplantar CFA-induced hyperalgesia. ASIC3 was increased in lumbar DRGs in
intraplantar CFA-induced hyperalgesia and decreased by EA at ST36 acupoint in mice. (a), (b) ASIC3 immunoreactive neurons were found in
lumbar DRGs in both ipsilateral and contralateral site of saline-injected group. (c) ASIC3 immunoreactive neurons were increased in ipsilateral site
of CFA-induced inflammation. (d) ASIC3 immunoreactive neurons were not increased in contralateral site of CFA-induced inflammation. (e) CFA-
induced increase of ASIC3 was attenuated by EA in ipsilateral site of inflammation. (f) ASIC3 immunoreactive neurons were not altered by EA in
contralateral site of inflammation. Arrows indicated immunoreactive neurons of ASIC3.
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left panel, n = 9). ASIC3 proteins consistently increased
with carrageenen-induced inflammation (Figure 4a, mid-
dle panel, 110.8 ± 0.1% compared with control group,
n = 9, p < 0.05). These patterns were not observed in
the contralateral site (Figure 4b, middle panel, 98.6 ±
0.1% compared with control group, n = 9, p > 0.05).
The increased expression of ASIC3 proteins could be
down-regulated with a 2 Hz electrical stimulation at the
ST36 acupoint at the inflammation site (Figure 4a, right
panel, 99.4 ± 3.1% compared with inflamed group, n =
9, p < 0.01) but not at the contralateral site (Figure 4b,
right panel, 98.9 ± 2.4% compared with inflamed group,
n = 9, p > 0.05). Low frequency electrical stimulation at
the ST36 acupoint decreased carrageenan-induced high
levels of ASIC3 expression. Similar results were also
observed in CFA-induced inflammation. In the controls,
ASIC3 existed in both ipsilateral (Figure 4c, left panel,
n = 9) and contralateral DRG neurons (Figure 4d, left
panel, n = 9). ASIC3 increased in the CFA-injected
group (Figure 4c, middle panel 137.1 ± 2.2% compared
with control group, n = 9, p < 0.01). These results were
not found in the contralateral site (Figure 4d, middle
panel, n = 9, p > 0.05). The increased expression of
ASIC3 was down-regulated by a 2 Hz EA at the ST36
acupoint in the ipsilateral (Figure 4c, right panel, 97.4 ±
3.7% compared with inflamed group, n = 9, p < 0.01),
but not the contralateral, site (Figure 4d, right panel,
98.3 ± 2.4% compared with inflamed group, n = 9, p >
0.05). These results demonstrated that low frequency
EA at the ST36 acupoint can successfully reverse
inflammation-induced ASIC3 overexpression in both the
carrageenen and CFA-induced models.
3.5 The expression of ASIC3 was increased by intraplantar
carrageenan and CFA injection and reversely down-
regulated by EA manipulation using Real-time PCR
We used Real-time PCR to further test if the ASIC3
mRNA quantity was consistently increased with inflamma-
tion. In control, ASIC3 mRNA was normally and similarly
existed in both ipsilateral (Figure 5, 100 ± 8.8%, n = 3) and
contralateral DRG neurons (Figure, 100 ± 5.8%, n = 3).
ASIC3 mRNA was increased with carrageenen-induced
inflammation (Figure 5, 291.7 ± 3.3% compared with con-
trol group, n = 3, p < 0.01). Similar results were not
observed in the contralateral site (Figure 5, 91.4 ± 5.3%
compared with control group, n = 3, p > 0.05). The
enhanced expression of ASIC3 mRNA could be further
down-regulated with a 2 Hz EA at the inflammation site
(Figure 5, 58.8 ± 22.1% compared with control group, n =
3, p > 0.05) but not at the contralateral site (Figure 5,
68.3 ± 17.3% compared with control group, n = 3, p >
0.05). Low frequency EA ameliorated carrageenan-induced
increase of ASIC3 expression. Similar phenomena were
also observed in CFA-induced inflammation. In control,
ASIC3 was expressed in both ipsilateral (Figure 5, 100 ±
4.4%, n = 3) and contralateral DRG neurons (Figure 5,
100 ± 6.2%, n = 3). The mRNA was increased in the CFA-
injected group (Figure 5, 451.5 ± 17.2% compared with
Figure 4 ASIC3 was increased in lumbar DRGs in both intraplantar carrageenan- and CFA-induced hyperalgesia. ASIC3 was increased in
lumbar DRGs in both intraplantar carrageenan- and CFA-induced hyperalgesia and further attenuated by EA at ST36 acupoint in mice. (a) ASIC3
proteins were increased in ipsilateral site of carrageenan-mediated inflammation and ameliorated by EA at ST36 acupoint (b) ASIC3 proteins
were not changed in contralateral site of carrageenan-mediated inflammation and EA stimulation. (c) ASIC3 proteins were increased in ipsilateral
site of CFA-induced inflammation and attenuated by EA at ST36 acupoint (d) ASIC3 proteins were not altered in contralateral site of CFA-
mediated inflammation and EA stimulation.
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control group, n = 3, p < 0.01). These phenomena were
not observed in the contralateral site (Figure 5, 96.3 ±
15.1%, n = 3, p > 0.05). The enhanced expression of
ASIC3 mRNA was decreased by low frequency EA in the
ipsilateral (Figure 5, 237.6 ± 4.5% compared with inflamed
group, n = 3, p < 0.01), but not the contralateral site
(Figure 5, 115.1 ± 7.9% compared with inflamed group,
n = 3, p > 0.05). The above results suggested that 2 Hz EA
at the ST36 acupoint can reliably reduced inflammation-
induced ASIC3 mRNA overexpression in both the carra-
geenen and CFA-induced models.
4. Discussion
In the current study, we first established an animal model
of inflammatory pain with a microinjection of carrageenan
and CFA. Animals with inflammatory pain showed
mechanical hyperalgesia using a von Frey filament test.
Stimulation with a 2 Hz EA at the ST36 acupoint success-
fully reduced inflammatory hyperalgesia in both carragee-
nan and CFA groups. ASIC3 expression increased with
inflammatory hyperalgesia and was then down-regulated
with a 2 Hz EA stimulation, as observed with immunohis-
tochemistry staining and Western blot technique. We
further examined the physiological function of ASIC3
using a whole cell recording technique. Our results
showed that both the amplitude and percentage of ASIC3-
like currents were potentiated in inflammatory hyperalge-
sia and decreased in the EA group. These phenomena
revealed the crucial role of ASIC3 in inflammatory
hyperalgesia and the therapeutic role of EA at the ST36
acupoint.
Recent studies have shown that injections of inflamma-
tory inducers result in Nav, TRPV1 and ASIC3 overex-
pression in DRG neurons [2,30,31]. ASIC3 in primary
afferent fibers respond to mechanical hyperalgesia of the
paw after inflammatory inducer or repeated acid injection
in GM [7,29]. Intramuscular injection of non-selective
ASIC blocker amiloride or selective blocker A-317567
prevents mechanical hyperalgesia in mice [2,29]. Interest-
ingly, in the ASIC3 -/- mice model, ASIC3 is not neces-
sary for thermal pain sensation since deletion of the
ASIC protein does not alter its function. The number of
ASIC3 channels greatly increased simultaneously in both
primary and secondary hyperalgesia. This phenomenon
indicated that attenuated ASIC3 overexpression is a
potential tool for hyperalgesia formation. Here we
reported that a 2 Hz EA at the ST36 acupoint can reduce
carrageenan- and CFA-induced inflammatory pain
through attenuating ASIC3 overexpression in peripheral
DRG neurons.
Previous studies have shown that transcutaneous electri-
cal nerve stimulation (TENS) has the ability to reduce sec-
ondary mechanical hyperalgesia of the paw induced by
knee joint inflammation [32,33]. Recently, Vance and col-
leagues have shown that primary mechanical hyperalgesia
induced by joint inflammation can be treated by both low-
and high-frequency TENS. The hyperalgesia withdrawal
threshold was attenuated at 24 hours and 2 weeks after
inflammation but not 4 hours. This suggested that the
effect of TENS on inflammatory hyperalgesia operates in a
time-dependent manner [34]. For TENS, electrodes are
often applied to the injury site. TENS is effective but only
for a short time. The patient must continue receiving
treatment for several days. Recent studies have also shown
that giving either low- or high-frequency TENS on the
ipsilateral or contralateral sides can reduce hyperalgesia
[32,35]. Both low and high frequency TENS-induced
analgesia was attenuated in a2A mutant mice. This phe-
nomenon was also observed with the application of a2
AR-selective antagonist at the peripheral level [33]. Periph-
eral opiate release is also involved in analgesia produced
by low frequency TENS. Blockade of μ-opioid receptors
prevents the curative effect of low, but not high, frequency
TENS [32].
The role of the peripheral and central opioid system in
attenuating inflammatory pain has been well-studied [26].
Intraplantar injection of opioid receptor antagonist nalox-
one can successfully reverse the analgesic effect of EA
treatment [36]. Recently, blockage of b-endorphin and
corticotropin-releasing factor (CRF) also reduced EA
analgesia. A 2 Hz low frequency EA induces the release of
enkephalin, while a 100 Hz high frequency EA increases
the release of dynorphin in the rat [26]. This result can
Figure 5 Comparative quantitative Real-time PCR analysis for
ASIC3 mRNAs from control. Comparative quantitative Real-time
PCR analysis for ASIC3 mRNAs from control, inflamed and EA
groups. ASIC3 mRNA was reliably increased in lumbar DRGs in both
carrageenan- and CFA-induced inflammation pain and further
reduced by EA at ST36 acupoint in mice. There is an only unilateral
increase in ASIC3 mRNA 24 hours after carrageenan or CFA-induced
inflammation. **Significantly greater than control mice (p < 0.01). ##
Significant difference compared with inflamed mice (p < 0.01).
Chen et al. Journal of Biomedical Science 2011, 18:82
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also be seen in humans [37]. Goldman et al. reported that
adenosine, a neuromodulator which serves an analgesic
function, can be released through acupuncture to relieve
inflammation and neuropathic pain. The curative effective
of adenosine requires A1 receptor activation, since this
phenomenon cannot be observed in mice lacking A1
receptors [28]. Direct application of an A1 receptor ago-
nist reduced pain sensation. Similar results can be seen by
inhibiting enzymes involved in adenosine degradation.
The above studies have shown that the opioid and adeno-
sine systems may participate in an analgesic role in both
manual and electro-acupuncture. In the current study, we
found that ASIC3, one of the most sensitive channels in
peripheral inflammatory pain, also modulates the hyperal-
gesia process and can be regulated by a 2 Hz EA stimula-
tion. ASIC3 mediates the effects of the 2 Hz EA.
Interfering with down-regulation of ASIC3 expression
may prolong the clinical benefit of EA.
5. Conclusions
In summary, we tested the changes in the behavior of
ASIC3 protein expression and ASIC3 currents after indu-
cing inflammation with carrageenan and CFA. Mechanical
hyperalgesia features were observed in both carrageenan
and CFA inflammation models. The mice which received
2 Hz electroacupuncture showed more analgesic reactions
to inflammation than those with carrageenan- and CFA-
inflammation. We, thus, further examined the ASIC3 pro-
tein expression using immunohistochemistry and western
blot analysis. Our results showed that ASIC3 greatly
increased in both carrageenan- and CFA-induced inflam-
mation. This phenomenon was significantly reversed with
a 2 Hz EA at the ST36 acupoint. These findings suggest
that ASIC3 is involved in inflammatory hyperalgesia and
that the traditional EA acupoint has a curative effect in
these inflammation models.
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